Integrated diagnostics combining histopathology, molecular, genomic, radiologic, and clinical data for disease classification and patient management

From November 2025

Ultrasensitive ctDNA detection is highly prognostic for NSCLC, improving disease stratification (ref: Black doi.org/10.1016/j.cell.2025.10.020/)
TRIM25 ablation enhances the efficacy of cancer immunotherapy by regulating VISTA (ref: Sun doi.org/10.1038/s41422-025-01186-5/)
AI technologies are transforming risk assessment and management in acute myeloid leukemia (ref: Ansarian doi.org/10.1001/jamaoncol.2025.3601/)
APTw MRI improves diagnostic accuracy for glioblastoma, aiding in differentiation of progression types (ref: Zeyen doi.org/10.1093/neuonc/)
Genome-wide association studies reveal new genetic insights into IgG4-related disease (ref: Yan doi.org/10.1016/j.ard.2025.10.028/)
Cell death drives IL-1β secretion in human monocytes, impacting inflammatory disease management (ref: Vande Walle doi.org/10.1038/s41590-025-02319-z/)
CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detection, enhancing diagnostic capabilities (ref: Jang doi.org/10.1093/nar/)
E-RCA platform integrates primer regeneration and signal amplification, improving nucleic acid detection (ref: Shang doi.org/10.1021/jacs.5c12435/)

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec